DUBLIN--(BUSINESS WIRE)--The 'Europe Clinical Laboratories Tests Market - Focused Insights 2024-2029' report has been added to ResearchAndMarkets.com's offering.

都柏林--（商业新闻短讯）--“欧洲临床实验室测试2024-2029年以市场为中心的见解”报告已添加到ResearchAndMarkets.com的产品中。

European Clinical Laboratories Tests Market is projected to reach a value of $69.1 billion in 2029 from $59.06 billion in 2023, growing at a CAGR of 2.7%

欧洲临床实验室测试市场预计将从2023年的590.6亿美元增长到2029年的691亿美元，复合年增长率为2.7%

The Europe clinical laboratory tests market report contains exclusive data on 36 vendors. The European market is highly competitive, and consolidation is expected to persist. Furthermore, more health system laboratories are expanding their reach and services, leading to heightened competition in clinical laboratory testing..

《欧洲临床实验室测试市场报告》包含36家供应商的独家数据。欧洲市场竞争激烈，预计整合将持续。此外，更多的卫生系统实验室正在扩大其范围和服务，导致临床实验室测试的竞争加剧。。

This competition arises from physicians within these health systems and independent physicians operating within the service areas of these health system laboratories. Many healthcare provider organizations are consolidating to create integrated healthcare delivery systems with greater market power. The leading companies include Synlab, Sonic Healthcare, Unilabs, Cerba, SCM Biogroup, and Labcorp..

这种竞争来自这些卫生系统内的医生和在这些卫生系统实验室的服务领域内运作的独立医生。许多医疗保健提供者组织正在整合，以创建具有更大市场影响力的集成医疗保健服务系统。领先的公司包括Synlab、Sonic Healthcare、Unilabs、Cerba、SCM Biogroup和Labcorp。。

Germany held the largest share, 18%, in the European clinical laboratory tests market in 2023. Germany's robust healthcare system and focus on research and innovation have positioned it as a leading market for cutting-edge diagnostic technologies. Laboratory testing capacities in Germany were around 2.36 million tests per week in 2023, with only around 2,84,000 PCR tests performed in the last week of 2022.

2023年，德国在欧洲临床实验室测试市场中占有最大份额，占18%。德国强大的医疗保健体系以及对研究和创新的关注，使其成为尖端诊断技术的领先市场。2023年，德国的实验室检测能力约为每周236万次，2022年最后一周仅进行了284000次PCR检测。

The average PCR test price amounted to $45.55 in 2022, 11% less than in 2021..

2022年，PCR检测的平均价格为45.55美元，比2021年低11%。。

MARKET TRENDS & DRIVERS

市场趋势和驱动因素

Increasing Outsourcing of Clinical Laboratory Testing

增加临床实验室检测外包

Subcontracting and outsourcing by public and private hospital laboratories to benefit private organizations is a trend observed in the European clinical laboratory services sector, which hospital operators mainly drive. It is expected that subcontracting and outsourcing could represent a growing source of income for companies operating in this sector.

公立和私立医院实验室的分包和外包使私营组织受益是欧洲临床实验室服务部门的一种趋势，医院运营商主要推动这一行业。预计分包和外包可能成为该行业运营公司不断增长的收入来源。

Early in the COVID-19 pandemic, with non-essential labs forced to close, many turned to outsourcing providers to continue serving their customers..

在新型冠状病毒大流行的早期，非必要的实验室被迫关闭，许多人转向外包供应商继续为客户服务。。

Due to the need to meet increased safety protocols for lab tests, lab managers must re-think their approach to completing work and identify more creative solutions than traditional approaches, including outsourcing laboratory operations that were not outsourced so that scientists can focus on higher-value tasks.

由于需要满足增加的实验室测试安全协议，实验室管理人员必须重新思考他们完成工作的方法，并确定比传统方法更具创造性的解决方案，包括外包未外包的实验室操作，以便科学家可以专注于更高价值的任务。

This promises to streamline healthcare operations and significantly improve patient outcomes by providing more accurate, efficient, and secure healthcare services..

这有望通过提供更准确，高效和安全的医疗保健服务来简化医疗保健操作并显着改善患者的预后。。

Rising Popularity of Digital Pathology Platforms

数字病理学平台的日益普及

In numerous European regions, pathology practices increasingly adopt digital methods, replacing traditional routines with digital imaging. However, the journey toward digital pathology is not always straightforward. With rapid technological advances, it is crucial to recognize that transitioning to a digital approach will impact various aspects of daily operations in pathology laboratories..

在许多欧洲地区，病理学实践越来越多地采用数字方法，用数字成像取代传统的常规。然而，走向数字病理学的旅程并不总是一帆风顺的。随着技术的快速进步，至关重要的是要认识到向数字方法的转变将影响病理实验室日常操作的各个方面。。

Meticulous planning and practical considerations are essential for a seamless shift toward an efficient digital workflow. Digital pathology is a multifaceted undertaking that demands careful planning from the outset. The preparatory phase should thoroughly analyze each institute's specific requirements, status, and objectives, recognizing that there is no one-size-fits-all solution.

细致的规划和实际考虑对于无缝转向高效的数字工作流程至关重要。数字病理学是一项多方面的事业，需要从一开始就仔细规划。准备阶段应彻底分析每个研究所的具体要求、地位和目标，认识到不存在一刀切的解决方案。

Before investing in significant equipment such as scanners, conducting trial phases with structured performance evaluations is advisable..

在投资扫描仪等重要设备之前，建议先进行结构化性能评估的试验阶段。。

To ensure digital pathology maintains diagnostic quality equivalent to conventional methods, laboratories must conduct validation studies encompassing the entire digital pathology process, including supplementary tools like image analysis software, following established guidelines or best practices.

为了确保数字病理学保持与常规方法相当的诊断质量，实验室必须按照既定的指南或最佳实践，进行涵盖整个数字病理学过程的验证研究，包括图像分析软件等补充工具。

While overall acceptance of digital pathology appears to be high, individual pathologists may vary in their affinity for digital workflows. Creating a user-friendly, intuitive, and ergonomic digital workspace requires concerted effort but can greatly facilitate the transition to routine digital diagnostics..

虽然数字病理学的总体接受程度似乎很高，但个别病理学家对数字工作流程的亲和力可能会有所不同。创建一个用户友好、直观且符合人体工程学的数字工作空间需要共同努力，但可以极大地促进向常规数字诊断的过渡。。

INDUSTRY RESTRAINTS

行业限制

High cost associated with Specialized Testing

与专业测试相关的高成本

The high cost of specialized diagnostic services may restrain growth during the forecast period. The increasing geriatric population in Europe, which is more susceptible to chronic infections, refrains from opting for these diagnostic services due to a lack of economic compatibility. Creating specialized tests involves extensive R&D, demanding a large investment, which is frequently passed on to the consumer, impeding business expansion..

在预测期内，专业诊断服务的高成本可能会抑制增长。欧洲越来越多的老年人更容易受到慢性感染，由于缺乏经济兼容性，因此无法选择这些诊断服务。创建专门的测试需要大量的研发，需要大量的投资，这经常会传递给消费者，阻碍业务扩展。。

SEGMENTATION INSIGHTS

细分见解

INSIGHT BY TEST COMPLEXITY TYPE

按测试复杂性类型划分的洞察力

The Europe clinical laboratory tests market by test complexity is segmented into specialty laboratory tests and routine laboratory tests. The routine tests segment occupied the largest market share of over 60% in 2023. Routine tests, majorly CLAI-waiver tests, are performed in many clinical laboratories.

。2023年，常规测试部门占据了超过60%的最大市场份额。常规测试，主要是CLAI豁免测试，在许多临床实验室中进行。

Most clinical laboratory tests are routine and performed on the whole blood, serum, plasma, and other body fluids such as urine and blood cell counts, thus helping segmental growth..

。。

INSIGHT BY TEST TYPE

按测试类型列出的洞察力

The Europe clinical laboratory tests market by test type is categorized into clinical & immunochemistry, molecular diagnostics, hematology, microbiology & cytology, and toxicology. The molecular diagnostics segment showcases significant growth, with the fastest-growing CAGR of over 5% during the forecast period..

欧洲临床实验室测试市场按测试类型分为临床和免疫化学、分子诊断学、血液学、微生物学和细胞学以及毒理学。分子诊断部门显示出显着的增长，在预测期内增长最快的复合年增长率超过5%。。

The presence of favorable reimbursement policies coupled with rising government support in the form of funding and initiatives for the development of diagnostic tests is anticipated to drive molecular diagnostics growth over the forecast period. In recent years, molecular diagnostics across Europe have seen significant advancements and widespread adoption.

有利的报销政策的存在，加上政府对诊断测试开发的资金和举措的支持不断增加，预计将在预测期内推动分子诊断的增长。。

Molecular diagnostics involves detecting and analyzing nucleic acids such as DNA and RNA, proteins, and other molecules at the molecular level to diagnose diseases, predict patient outcomes, and guide treatment decisions..

分子诊断涉及在分子水平上检测和分析核酸，如DNA和RNA，蛋白质和其他分子，以诊断疾病，预测患者预后并指导治疗决策。。

INSIGHT BY PROVIDER TYPE

按提供程序类型列出的洞察力

The hospital-based clinical laboratory segment dominates with the largest market share in 2023. Hospital-based clinical laboratories in Europe are integral to healthcare systems, providing essential diagnostic services to support patient care, treatment decisions, and disease management. In the healthcare sector, hospital-associated laboratories are at the forefront for patients..

2023年，以医院为基础的临床实验室部门占据了最大的市场份额。欧洲的医院临床实验室是医疗保健系统不可或缺的组成部分，提供必要的诊断服务，以支持患者护理，治疗决策和疾病管理。在医疗保健领域，医院相关实验室处于患者的最前沿。。

Hospital settings are the primary contributors to clinical lab services, with the potential to deliver lab tests and diagnostics for outpatient and inpatient requirements and walk-in consumers looking to benefit from the facilities' clinical expertise after receiving the results, thus helping segmental growth..

医院环境是临床实验室服务的主要贡献者，有可能为门诊和住院患者提供实验室测试和诊断，以及希望在收到结果后从设施的临床专业知识中受益的步入式消费者，从而有助于分部增长。。

KEY QUESTIONS ANSWERED

回答的关键问题

How big is the Europe clinical laboratory tests market?

欧洲临床实验室测试市场有多大？

Who are the major European clinical laboratory test market players?

谁是欧洲临床实验室测试市场的主要参与者？

What is the growth rate of the Europe clinical laboratory tests market?

欧洲临床实验室测试市场的增长率是多少？

What are the trends in the Europe clinical laboratory tests market?

？

Key Attributes:

关键属性：

Report Attribute

报表属性

Details

详细信息

No. of Pages

页数

87

87

Forecast Period

2023 - 2029

2023 - 2029

Estimated Market Value (USD) in 2023

2023年估计市值（美元）

$59.06 Billion

590.6亿美元

Forecasted Market Value (USD) by 2029

2029年预测市场价值（美元）

$69.1 Billion

691亿美元

Compound Annual Growth Rate

年均复合增长率

2.6%

2.6%

Regions Covered

覆盖的区域

Europe

欧洲

VENDORS LIST

供应商列表

Key Vendors

主要供应商

Synlab

Synlab

Sonic Healthcare

Sonic Healthcare公司

Unilabs

Unilabs

Cerba HealthCare

塞尔巴医疗保健

SCM BIOGROUP

SCM生物群

Labcorp

Labcorp

Other Prominent Vendors

其他知名供应商

ACM Global Laboratories

ACM全球实验室

Quest Diagnostics

奎斯特诊断公司

Siemens Healthineers

西门子Healthineers

Genando

组织

Eurofins Scientific

欧陆科学

MLM Medical Labs

传销医学实验室

Myriad Genetics

巨数遗传公司

Labor Berlin

柏林劳工局

LKF Central Laboratories

李锦记中央实验室

Genova Diagnostics

Genova诊断

Cyrex Labs

Cyrex实验室

Q2 Solutions

第二季度解决方案

Nelson Labs

Nelson实验室

Centogene

Centogene

HCA Healthcare UK Laboratories

HCA医疗保健英国实验室

Amedes

修改

Catlab

Catlab

Charles River

查尔斯河

Mayo Clinic Laboratories

梅奥诊所实验室

NADMED Laboratory

NADMED实验室

Fresenius Medical Care

费森尤斯医疗

Vall d'Hebron University Hospital

瓦尔德希布伦大学医院

Cambridge Clinical Laboratories

剑桥临床实验室

Exeter Clinical Laboratory

埃克塞特临床实验室

Newcastle Laboratories

纽卡斯尔实验室

SIPMeL

西普梅尔

Medica Medizinische Laboratorien

医学实验室

Bioexcel

Bioexcel

Alpine BioMedical

阿尔卑斯生物医学

UZ Leuven

UZ鲁汶

SEGMENTATION & FORECAST

细分和预测

By Test Complexity

Specialty Laboratory Tests

专业实验室测试

Routine Laboratory Tests

常规实验室测试

By Test Type

按测试类型

Clinical & Immunochemistry

临床与免疫化学

Molecular Diagnostics

分子诊断学

Hematology

血液学

Microbiology & Cytology

微生物学和细胞学

Toxicology

毒理学

By Providers

按提供商

Hospital-Based Laboratories

医院实验室

Independence & Standard Reference Laboratories

独立和标准参考实验室

Others

其他

By Region

按地区

Germany

德国

France

法国

Italy

意大利

Spain

西班牙

UK

英国

For more information about this report visit https://www.researchandmarkets.com/r/8e2shr

有关此报告的更多信息，请访问https://www.researchandmarkets.com/r/8e2shr

About ResearchAndMarkets.com

关于ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

ResearchAndMarkets.com是全球领先的国际市场研究报告和市场数据来源。我们为您提供有关国际和地区市场、关键行业、顶尖公司、新产品和最新趋势的最新数据。